WinwinGPT 即將上線,加入 Waitlist 上線搶先用!

Davita inc

美股醫療保健

DVA 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面評分優異,但股利評分未超過2分,若公司開始配息,可能會有更優異的投資結果

DVA 近期報酬表現

1.18%

Davita inc

2.86%

同產業平均

0.86%

S&P500

與 DVA 同產業的標的表現

  • FMS Fresenius medical care ag
    價值 4 分趨勢 3 分波段 2 分籌碼 1 分股利 5 分
    查看更多

DVA 公司資訊

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company's robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company's international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company's U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DVA 股價